FAQ: What are the consequences of NASH going untreated?

Thank you to Madrigal for sponsoring this FAQ Video Module.

In this GHAPP FAQ Video Module, Corrie Berk, NP, Director of Hepatology and Transplant Outreach Programs at the Texas Liver Institute, shares insights on the consequences of untreated metabolic-associated steatohepatitis (MASH) and the importance of early intervention. She discusses how MASH can silently progress to liver failure, liver cancer, and increase cardiovascular risks. Corrie provides valuable strategies for advanced practice providers (APPs) to educate patients, focusing on simplifying complex information, promoting lifestyle changes, and emphasizing the benefits of early intervention. For more information on MASH, visit the GHAPP website or app.